Provided by Tiger Trade Technology Pte. Ltd.

Reviva Pharmaceuticals Holdings, Inc.

0.8069
-0.0201-2.43%
Volume:285.00K
Turnover:235.62K
Market Cap:10.27M
PE:-0.09
High:0.8510
Open:0.8510
Low:0.8004
Close:0.8270
52wk High:23.40
52wk Low:0.6697
Shares:12.73M
Float Shares:12.55M
Volume Ratio:0.25
T/O Rate:2.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.8000
EPS(LYR):-18.0520
ROE:-916.17%
ROA:-130.48%
PB:2.26
PE(LYR):-0.04

Loading ...

May 31, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 29, 2024

Major Issues Report

Form 8-K - Current report
May 17, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 15, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 15, 2024

Major Issues Report

Form 8-K - Current report
Apr 15, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 15, 2024

Major Issues Report

Form 8-K - Current report
Apr 15, 2024

Major Issues Report

Form 8-K - Current report
Feb 16, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2024

Correspondence

Form CORRESP - Correspondence
Nov 30, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Nov 18, 2023

Major Issues Report

Form 8-K - Current report
Nov 15, 2023

Major Issues Report

Form 8-K - Current report
Nov 15, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]
Nov 15, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 14, 2023

Major Issues Report

Form 8-K - Current report